Anti-Inflammatory Compounds of Plant Origin. Part II. Modulation of Pro-Inflammatory Cytokines, Chemokines and Adhesion Molecules

Table of Contents

Abstract

It has been widely shown that many plant-derived compounds present significant anti-inflammatory effects. For this reason, they represent potential molecules for the development of new drugs, especially designed for the treatment and/or control of chronic inflammatory states such as rheumatism, asthma, inflammatory bowel diseases, atherosclerosis, etc. This review focuses on the naturally-occurring compounds with anti-inflammatory properties and attempts to correlate their actions with the modulation of cytokines and associated intracellular signalling pathways; it continues the review published in the November, 2003 issue of Planta Medica.

Abbreviations

AP-1:activator protein-1

CCR1:chemokine receptor 1

CINC-1:cytokine-induced neutrophil chemoattractant 1

COX:cyclooxygenase

EGCG:(-)-epigallocatechin gallate

ELAM-1:endothelial-leukocyte adhesion molecule-1

ERK:extracellular signal-regulated kinase

GRO:growth-related oncogene

HUVEC:human umbilical vein endothelial cells

ICAM-1:intercellular adhesion molecule-1

IFN:interferon

IL:interleukin

iNOS:inducible nitric oxide synthase

IRA:the natural interleukin receptor activation

JAK:janus kinase

JNK:c-Jun NH2-terminal kinase

LPS:lipopolysaccharide

MAPK:mitogen-activated protein kinases

MCP:monocyte chemotactic protein

MHC:major histocompatibility complex

MIP:macrophage inflammatory protein

MMP:matrix metalloproteinases

MPO:myeloperoxidase

NF-κBnuclear factor kappa B

NO:nitric oxide

PAF:platelet aggregation factor

PGEE:prostaglandin

PK:protein kinase

PMA/TPA:phorbol myristate acetate

RANTES:regulated upon activation normal T-cell expressed and secreted

TGF-β:transforming growth factor-β

TNFα:tumour necrosis factor

VCAM-1:vascular cell adhesion molecule-1

Key words

Medicinal plants - plant constituents - inflammation - cytokines - chemokines - adhesion molecules

Introduction

The inflammatory process may be defined as a sequence of events that occurs in response to noxious stimuli, trauma or infection. These responses are orchestrated by a highly modulated interaction between mediators of inflammation and inflammatory cells [1]. Cytokines represent a group of multifunctional substances that are involved in many steps of the inflammatory response. Until now, more than 100 members of the cytokine family and their specific receptors have been identified [2], [3], [4]. Generally, cytokines can be classified as pro- or anti-inflammatory, depending on the way they influence inflammation. In a more simplified view, pro-inflammatory cytokines (e. g., IL-1β, TNFα, IL-6 and IL-18) seem to be involved in the initiation and amplification of the inflammatory process, whereas the anti-inflammatory cytokines (e. g., IL-10, TGF-β and IRA) negatively modulate these events [5], [6].

Cytokines are produced by both resident and migrating cells, such as mast cells, macrophages and neutrophils and, after release; they can act either locally or systemically. Due to their redundant and pleiotropic actions, cytokines form a network in which one cytokine can induce its own production or even the secondary generation of other cytokines. In addition, it has been widely shown that most cytokine actions involve the activation of transcription factors (e. g., NF-κB and AP-1) and protein kinases (e. g., MAPK and PKC) that, in turn, regulate the expression of many target genes indispensable to the maintenance of the inflammatory state [3], [7]. For instance, cytokines may be responsible for the induction of several enzymes (e. g., iNOS and COX-2), receptors (PAF receptor, IL-2 receptor) and adhesion molecules (E-selectin, α- and β-integrins, ICAM-1, VCAM-1) [3], [8], [9].

A distinct group of cytokines, denoted chemokines (including IL-8, eotaxin, GRO, CINC-1 and RANTES) have the ability to chemoattract and activate leukocytes at the site of inflammation [10], [11]. Chemokine effects are mediated via interaction with G protein-coupled receptors. Binding of chemokines to their specific receptors allows rolling leukocytes to become firmly adherent and able to transmigrate to the target tissue, a process largely dependent on the activation of adhesion molecules, mainly integrins [10], [12].

Recent evidence has indicated that cytokines (and chemokines), as well as their receptors, are involved in the pathophysiology of many inflammatory diseases, including sepsis, rheumatoid arthritis, atherosclerosis and asthma. These pathological states seem to be linked to an imbalance of the cytokine network and to the excessive recruitment of leukocytes to the inflammatory sites [3], [13], [15]. Because of this, the cytokine system constitutes a very interesting and promising target for the development of clinically relevant anti-inflammatory drugs. In fact, some specific cytokine modulators have been introduced into clinical practice during the last few years. Despite the effectiveness described for these drugs, their use is associated with some side effects [15], [16], [17] and, most important, with high cost. In this context, the identification of small molecule plant-derived compounds able to selectively interfere with the production and/or function of cytokines would constitute an important alternative for the treatment of many inflammatory diseases.

In the second part of this review we will focus on the recent contributions to the identification of naturally-occurring compounds derived from plants as potential modulators of the cytokine network and related cell migration process.

Phenolic Compounds

A substantial body of evidence obtained from both in vivo and in vitro studies supports the concept that various plant-derived compounds with anti-inflammatory properties exert their effects through the modulation of the cytokine system (for recent review see [18]). For instance, flavonoids, a class of compounds widely distributed throughout the plant kingdom, possess interesting anti-inflammatory actions [19], [20], [21]. Very recently, Xagorari et al. [22] have reported that luteolin (1) (IC₅₀ < 1 μM), quercetin (2) (IC₅₀ 1 μM), luteolin 7-glucoside (approximate IC₅₀ 50 μM) and the isoflavonoid genistein (IC₅₀ 5 μM) (3) inhibited LPS-stimulated TNFα and interleukin-6 release in RAW 264.7 macrophages, whereas eriodictyol and hesperetin only inhibited TNFα release (approximate IC₅₀ value of 50 μM). Luteolin also inhibited the production of TNFα in vivo and was capable of decreasing both PMA and oxazolone-induced allergic ear oedema [23]. Luteolin significantly reduced LPS-stimulated ICAM-1 expression in the liver of LPS (Salmonella enteriditis)-treated mice [24]. In a recent study, Das et al. [25] demonstrated that chronic administration of luteolin significantly attenuated ovalbumin-induced airway bronchoconstriction and bronchial hyperreactivity. Moreover, the same treatment with luteolin was capable of reducing the levels of both IL-4 and IL-5, whereas it induced an increase in IFNγ in the broncheoalveolar lavage fluid of sensitised mice [25]. These authors have suggested that luteolin could be used as a lead molecule to identify effective therapies for the treatment of asthma.

Manna et al. [26] demonstrated that silymarin, a mixture of bioactive flavonoids isolated from Silybum marianum L. (Asteraceae) was able to prevent, in a concentration-dependent manner, TNFα-induced NF-κB activation in human histiocytic lymphoma U-937 cells. Johnson et al. [27] also reported the effects of silymarin on the thymic lymphocyte population in mice. Intraperitoneal administration of silymarin (10 to 250 mg/kg, once a day, for five days) resulted in the augmentation of CD4+ and CD8+ thymic lymphocyte populations, by a mechanism involving an increase in c-myc expression. In addition, silymarin significantly decreased the expression of IL-2 and IL-4, without affecting MHC II expression in mouse lymphocytes [27].

It has been demonstrated that a citrus polymethoxyflavonoid, nobiletin (4) (5,6,7,8,3′,4′-hexamethoxyflavone) effectively inhibits the production of PGE₂ and proMMP-9 in rabbit synovial fibroblasts [28]. More recently, Lin et al. [29] have shown that nobiletin (IC₅₀ < 4 μM) suppressed IL-1β-induced production of PGE₂ in human synovial fibroblasts cells and decreased the expression of IL-1α, IL-1β, TNFα and IL-6 mRNAs in J774A.1 macrophages (at a concentration of 32 μM) [29]. These results allow the authors to suggest that nobiletin could be a candidate for the development of a novel anti-inflammatory or immunomodulatory drug.

Baicalin (5), baicalein (6) and wogonin (7) are flavonoids present in Scutellaria baicalensis Georgi (Lamiaceae), a plant used in the treatment of a variety of inflammatory diseases such as bronchitis, nephritis, hepatitis, asthma, and atopic dermatitis [30]. The anti-inflammatory activities of these flavonoids have been attributed to their antioxidant properties and to their ability to inhibit LPS-induced NO production and iNOS gene expression, as well as the increase in TNFα levels by RAW 264.7 cells [31], [32]. Li et al. [33] have demonstrated that baicalin (IC₅₀ values ranging from 15 to 320 μg/mL) and, to a lesser extent, baicalein, significantly inhibited the binding of several chemokines such as CXC, [stromal cell-derived factor (SDF)-1α and IL-8], CC [macrophage inflammatory protein (MIP)-1β, monocyte chemotactic protein (MCP)-2), and C lymphotactin (Ltn)] to human leukocytes or cells transfected with chemokine receptors. Baicalein also prevented eotaxin production (approximate IC₅₀ value of 1.8 μg/mL) and the mRNA eotaxin expression in human fibroblasts stimulated with IL-4 plus TNFα [34]. Confirming the in vitro studies, the co-injection of baicalein with interleukin-8 (IL-8) significantly inhibited IL-8-elicited neutrophil infiltration in rat skin. However, baicalin failed to block CX3C chemokine fractalkine/neurotactin or other cytokines, such as TNFα or IFN-γ [33]. Several studies have demonstrated that most flavonoids, including baicalein (IC₅₀ values ranging from 2.4 to 9.7 μM) inhibit IL-1β-, TNFα- and thrombin-induced endothelial leukocyte adhesion molecule-1 (ELAM-1) and ICAM-1 expression in cultured human umbilical vein endothelial cells (HUVEC) [19], [35]. Sartor et al. [36] have reported that different flavonoids (IC₅₀ values between 0.4 and 450 μM), such as flavones (baicalein), anthocyanidins (delphinidin and pelargonidin), flavanols [epigallocatechin-3-gallate (8)], flavonols [morin (9) and quercetin] and other compounds with antioxidant properties were highly effective in inhibiting the activities of leukocyte elastase, MMP-2 and MMP-9. Such actions might explain the anti-inflammatory, antiangiogenic, anti-invasive and antimetastatic properties described for these compounds. Krakauer et al. [37] have shown that baicalin (IC₅₀ values ranging from 3 to 50 μg/mL) inhibited the expression and production of IL-1β, IL-6, TNFα, IFNγ, MIP-1α/β in human peripheral blood mononuclear cells under stimulation with superantigenic staphylococcal exotoxins. More recently, Shen et al. [38] reported that baicalein and baicalin were able to decrease fMLP- or PMA-induced accumulation of reactive oxygen intermediates in human neutrophils and monocytes (IC₅₀ values ranging from 1.5 to 64.5 μM). Furthermore, baicalein and baicalin diminished the fMLP-induced increase in surface expression of the integrin MAC-1 (CD11b/CD18) and MAC-1-dependent neutrophil adhesion [38]. Baicalein and wogonin (approximate IC₅₀ values of 1 to 40 μM) were also effective in blocking the production and expression of IL-6 and IL-8 in a human retinal pigment epithelial cell line [39].

It has been recently reported that standardised extracts of Ginkgo biloba L. (IC₅₀ > 400 μg/mL) (Ginkgoaceae) (EGb 761) and its flavonoid component quercetin (IC₅₀ < 200 μg/mL) inhibited TNFα secretion in LPS-stimulated RAW 264.7 macrophages, by interfering with the phosphorylation and activation of JNK/SAPK and its downstream substrates c-Jun and ATF-2, and ERK1/2 and p38 MAPK. In addition, Wadsworth et al. [40] have shown that Ginkgo biloba extract (EGb 761) and quercetin suppress the activation of the transcription factor AP-1. Quercetin (IC₅₀ < 20 μM) [41] and quercetin 3-O-methyl ether from Rhamnus nakaharai Hayata (Rhamnaceae) [42], as well as amoradicin (IC₅₀ 28.5 μM) isolated from Amorpha fruticosa L. (Fabaceae) [43], markedly inhibited the production of TNFα in LPS-stimulated murine macrophages. Quercetin 3-O-methyl ether also caused a pronounced inhibition of TNFα formation according to an evaluation in LPS/IFN-γ-stimulated murine microglial N9 cells [42]. Luteolin 4′-O-glucopyranoside, cosmosiin, apigenin (10), luteolin, quercimeritrin and kaempferol, from Kummerowia striata Thumb. (Leguminosae) exhibited concentration-dependent inhibitory effects on IL-5 bioactivity, with mean IC₅₀ values of 3.7, 14.2, 16.4, 18.7, 27.3 and 30.0 μM, respectively [44].

Okabe et al. [45] reported that (-)-epigallocatechin gallate (EGCG) , the main constituent of green tea polyphenols, tannins [geraniin (11) and corilagin (12)] and the aqueous extract of leaves of Acer nikoense Maxim. (Aceraceae), a Japanese herbal medicine used for eye and liver diseases, effectively prevented TNFα release in BALB/3T3 cells stimulated with okadaic acid. The mean IC₅₀ values obtained were 26 μM for EGCG, 43 μM for geraniin, and 76 μM for corilagin. In addition, treatment of animals with geraniin (5 mg/site) and EGCG reduced the percentage of tumour-bearing mice from 80 to 40 % and 73 to 0 %, and the average number of tumours from 3.8 to 1.1 and 4.2 to 0, following topical application of 7,12-dimethylbenz[a]anthracene (DMBA) plus okadaic acid, respectively [45].

1,7-Bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one and procurcumenol present in the rhizomes of the plant Curcuma zedoaria L. (Zingiberaceae) were found to be effective in reducing the production of TNFα in LPS-activated macrophages, with mean IC₅₀ values of 12.3 μM and 310.5 μM, respectively [46]. Kang et al. [47] reported that hypericin (13), an active component of Hypericum perforatum L. (Hypericaceae), significantly inhibited in a concentration-dependent manner IL-12 production in LPS-activated macrophages (IC₅₀ 1.45 μg/mL). Hypericin potently inhibited the activation of the IL-12 gene promoter, suggesting that hypericin negatively regulated IL-12 production at the transcription level. Furthermore, Bork et al. [48] have demonstrated that hypericin inhibits PMA- and TNFα-induced activation of NF-κB by a mechanism not involving antioxidant pathways. These results might explain some known biological activities of hypericin, including its reported antirheumatic effects [48].

It has been demonstrated that a methanolic extract of the root cortex of Paeonia suffruticosa Andrews (Ranunculaceae), known as mudanpi, inhibited in a concentration-related manner the secretion of IL-8 and MCP-1 induced by PMA in human monocytic U937 cells (approximate IC₅₀ value of 35 μg/mL) [49]. Chou [50] demonstrated that its main active compound paeonol (2′-hydroxy-4′-methoxyacetophenone) (14), exhibited analgesic and anti-inflammatory effects in the rat model of carrageenan-evoked thermal hyperalgesia. The analgesic and anti-inflammatory effects of paeonol are associated with its ability to inhibit in a concentration-dependent manner the formation of several pro-inflammatory cytokines (such as TNFα, IL-1-β and IL-6), as well as the over-production of NO and PGE₂. In addition, the effects of paeonol are also associated with an increase in the anti-inflammatory cytokine IL-10, with inhibition of neutrophil infiltration and iNOS and COX-2 protein expression [50]. Thus, paeonol represents a potential candidate for the development of a new anti-inflammatory therapy.

Pycnogenol, a compound isolated from the bark of Pinus maritime Mill (Pinaceae) exhibited a marked scavenger activity when evaluated in the murine macrophage cell lines RAW 264.7 and IC-21 stimulated with H₂O₂ and PMA, respectively. Furthermore, pycnogenol was found to be effective in reducing both the production of IL-1β and the expression of IL-1β mRNA in LPS-stimulated RAW 264.7 cells, an effect dependent on interference with the transcription factors NF-κB and AP-1 [51]. Recently, Bito et al. [52] have shown that taxifolin (15) purified from pycnogenol reduced IFN-γ-induced ICAM-1 protein, as well as mRNA expression in human keratinocytes, by affecting the activation of the transcription factor STAT-1 and the protein tyrosine phosphorylation of Janus kinase (JAK)-1. This suggests that the JAK-STAT pathway might be the molecular site of action of taxifolin [52].

Manthey et al. [53] have shown that the polymethoxylated flavone, 3,5,6,7,8,3′,4′-heptamethoxyflavone (IC₅₀ 5 μM) inhibits LPS-induced expression and the production of TNFα, the chemokine MIP-1α and IL-10 in monocytes. The polymethoxylated flavone has been reported to inhibit human phosphodiesterase activity and has been shown to induce a great elevation of cAMP levels in monocytes [53]. Other preliminary studies have reported that different classes of naturally occurring substances, such as stilbenes isolated from Magnoliae fargesii Cheng (Magnoliaceae) produced a marked inhibition of the expression of ICAM-1 and VCAM-1 on the surface of THP-1 human monocytes [54], [55], [56]. Stilbenes, such as 3,5-dihydroxy-4′-methoxystilbene and 2,3,4′,5-tetrahydroxystilbene 2-O-β-D-glucopyranoside [as well as resveratrol (16)] were also effective in blocking TNFα-induced cell-cell adhesion between HUVECs and THP-1 cells [55]. Diarylheptanoids, such as 1-(3,5-dimethoxy-4-hydroxyphenyl)-7-phenylhept-1-en-3-one (YPE-01), yakuchinone B and demethylyakuchinone B, reduced the adhesion of both the human monocytic cell line U937 and the human eosinophilic cell line EoL-1 to TNFα-treated HUVECs (IC₅₀ values ranging from 29 to 67.2 μM) [57]. In addition, these compounds were also effective in suppressing both IL-1β- and TNFα-induced expression of E-selectin, VCAM-1 and ICAM-1 on the surface of the endothelial cells (IC₅₀ values ranging from 17.8 to 40.3 μM). Since YPE-01 reduces both VCAM-1 and ICAM-1 mRNA induction in TNFα-stimulated endothelial cells, the authors suggest that this compound suppresses adhesion molecule expression at the transcriptional level. Furthermore, YPE-01 given systemically suppressed TPA-induced ear oedema in mice [57].

Piceatannol, another phenolic compound known as a selective inhibitor of the Syk tyrosine kinase significantly prevented TNFα-induced NF-κB activation in lymphocytes and epithelial cells [58]. Some preliminary studies have indicated that other naturally occurring substances, such as the polyphenol chlorogenic acid, inhibit staphylococcal exotoxin-induced T cell proliferation (by 98 %) and the production of IL-1β, TNFα, IL-6, INF-γ, MCP-1, MIP-1α and MIP-1β by human peripheral mononuclear cells [59]. Reynosin exhibited a concentration-dependent inhibition of CINC-1 induction in LPS-stimulated NRK-52E rat kidney epithelioid cells with a mean IC₅₀ value of ˜1 μM [60].

Tsuda et al. [61] reported that oral administration of a typical anthocyanin, cyanidin 3-O-β-D-glucoside, suppressed the zymosan-induced inflammatory response in rats. Treatment of cyanidin 3-O-β-D-glucoside also reduced the elevation of NO_x, TNFα, IL-1β, IL-6 and CINC-1 concentrations. Furthermore, cyanidin 3-O-β-d-glucoside normalised the levels of several acute phase proteins, including α₂-macroglobulin, albumin and transferrin in the serum of rats treated with zymosan [61]. It has been recently demonstrated that phoroglucinol derivatives, purified from Mallotus japonicus Mueller Arg. (Euphorbiaceae) [e. g., isomallotochromanol (17) and isomallotochromene (18)] are effective in inhibiting the mRNA expression and production of TNFα or IL-6 in RAW 264.7 cells (IC₅₀ values ranging between 0.7 and 30 μM). These compounds also reduced the formation of TNFα and IL-6 by human blood monocytes activated with LPS, with IC₅₀ values ranging over a similar interval [62]. The effects described for these compounds seem to be dependent on the blockade of NF-κB activation, but might also include the inhibition of other pro-inflammatory pathways.

Among the polyphenols, the compound obtained from the rhizome of Curcuma longa L. (Zingiberaceae), curcumin (19), presents high interest as a lead compound to develop new clinically relevant anti-inflammatory drugs. Apart from its effect on inflammatory events (for review, see [63]) this compound significantly blocked IL-12 mediated T cell proliferation and Th₁ differentiation, an action that possibly implies its ability to reduce the production of pro-inflammatory cytokines [64]. Curcumin was found to significantly down-regulate the TNFα-induced increase in MMP-13 mRNA and protein expression in primary human chondrocytes and SW1353 cells by a mechanism involving the inhibition of NF-κB, c-jun and JNK [65]. Moreover, curcumin significantly inhibited the increase of both IL-1β and TNFα in a chronic model of inflammation in rats [66]. On account of these characteristics, curcumin has been submitted to clinical trials. According to a recent evaluation [67], curcumin has been shown to be safe in six human trials designed to test its anti-inflammatory activities. Due to its anti-inflammatory properties, the clinical potential of curcumin for prevention and treatment of cancer was also assessed [68], [69].

Hematein (20) is a compound isolated from Caesalpinia sappan Linn (Leguminosae), a plant employed in oriental medicine as an analgesic or anti-inflammatory [70]. Oh et al. [71] demonstrated that hematein was efficacious in reducing the expression of VCAM-1 in the aorta of hypercholesterolemic New Zealand rabbits. Hematein also efficiently reduced TNFα-induced VCAM-1 expression in HUVECs [72]. Hematein diminished the increase in VCAM-1 and MCP-1 levels induced by TNFα and oxidised LDL in HUVECs, respectively, as well as reducing TNFα and IL-1β production by peritoneal macrophages stimulated with LPS plus IFNγ. Furthermore, hematein also reduced the cell surface expression of adhesion molecules, resulting in the inhibition of THP-1 monocyte adhesion to TNFα stimulated HUVECs [73].

Lignans

Cho et al. [74] reported that 10 lignan constituents isolated from the rhizomes of Coptis japonica Makino (Ranunculaceae) including pinoresinol (21), woorenoside V (22) and lariciresinol glycoside had significant inhibitory effects on the TNFα production by LPS-activated RAW 264.7 cells. Five other dihydrobenzofuran neolignans, woorenosides (I - V), obtained from Coptis japonica Makino (Ranunculaceae), concentration-dependently blocked TNFα production by LPS-stimulated RAW 264.7 macrophages (IC₅₀ ranging from 15 to 60 μM) [75]. Other studies have demonstrated that some lignans, including savinin (IC₅₀ = 31.9 μM) and calocedrin (23) (IC₅₀ > 150 μM) isolated from the heartwood of Pterocarpus santalinus Makino (Leguminosae) [76], or pinoresinol, woorenoside V and lariciresinol glycoside (IC₅₀ values between 50 and 100 μM) obtained from rhizomes of Coptis japonica Makino [76], caused a significant inhibition of TNFα production in RAW 264.7 macrophages stimulated with LPS. In addition, the same lignans from Pterocarpus santalinus Makino (Leguminosae) also inhibited the T-cell proliferation elicited by concanavalin A, without displaying cytotoxic effects [77]. The sesquineolignans, named morinols A and B, isolated from the roots of the Chinese medicinal herb Morina chinensis P.Y. Pai (Dipsacaceae) produced a significant inhibition of cytokines formation, including TNFα, IL-4, IL-2 and IFN-γ in human peripheral blood mononuclear cells. However, morinol B (IC₅₀ > 10 μg/mL) exhibited a more pronounced activity than its isomer, morinol A [78]. Interestingly, recent data indicate that LPS-treated mice fed a sesamol diet showed a reduction in IL-6 levels in the plasma [79]. Likewise, LPS-treated rats fed with a sesamin-supplemented diet presented reduced TNFα levels in the plasma [80]. Finally, six lignans isolated from Magnoliae fargesii Cheng (Magnoliaceae) produced a marked inhibition of the expression of ICAM-1 and VCAM-1 on the surface of THP-1 human monocytes (IC₅₀ values between 20 and 60 μM) [81].

Terpenes

Recently, it has been reported that an extract of Tripterygium wilfordii Hook F (Celastraceae) markedly inhibited mRNA synthesis and protein expression of MMP-3 and MMP-13, induced by the pro-inflammatory cytokines IL-1β, IL-17 and TNFα as assessed in primary osteoarthritic human or normal bovine chondrocytes (IC₅₀ > 5 ng/mL) [82]. The authors have suggested that the extract of T. wilfordii could be useful as a source and template for novel antiarthritic and cartilage-protective drugs [82]. In addition, celastrol (24) (IC₅₀ values between 30 and 100 nM) decreased the production of the pro-inflammatory cytokines TNFα and IL-1β in human monocytes and macrophages. Celastrol (3 mg/kg) has also been reported to inhibit rat adjuvant-induced arthritis, thus confirming its reported in vitro anti-inflammatory properties. It has been proposed that celastrol might be useful for improving performance in memory, learning and psychomotor activities, and common features of the neurodegenerative diseases accompanied by inflammation, such as Alzheimer’s disease [83]. In addition, it was demonstrated that structurally different sesquiterpene lactones, which possess an α-methylene-γ-lactone function and a conjugated carbonyl group, reduced the production of IL-1β, TNFα and IL-6 in adherent mouse peritoneal exudate cells in a concentration-dependent manner (IC₅₀ ranging between 0.69 and 1.70 μM) [84]. Schnyder et al. [85] have reported that parthenolide (25) (IC₅₀ < 10 μM) blocked the VCAM-1 expression induced by IL-4 in endothelial cells. It was recently shown that parthenolide and the other terpenic compounds isolantolactone and alantolactone decreased the expression of IL-2 in T-lymphocytes [86].

It has been recently reported that ginsenosides Rb1 (26) and Rb2 (27), the major constituents of Panax ginseng C.A. Meyer (Araliaceae), are effective in inhibiting TNFα production in RAW 264.7 and U937 cells stimulated with LPS. The mean IC₅₀ values observed were 56.5 and 51.3 μM for Rb1 and 27.5 and 26.8 μM for Rb2, in RAW264.7 and U937 cells, respectively [87]. The inhibitory activity of Rb1 and Rb2 was significantly increased by inhibitors of protein kinase C and A, protein tyrosine kinase or by drugs used for the treatment of arthritis (chloroquine and steroid drugs), but not by AMP phosphodiesterase inhibitors. The authors suggested that ginsenosides could be of clinical interest for the management of TNFα-mediated diseases, such as arthritis [87].

The terpenic saponin kalopanaxsaponin A (28) (approximate IC₅₀ value 5 μM) isolated from Kalopanax pictus Nakai (Araliaceae) prevented the formation of TNFα by RAW 264.7 macrophages stimulated with LPS at concentrations up to 5 μM [88]. Huang et al. [89] reported that tripterine (29) isolated from Tripterygium wilfordii Hook F. (Celastraceae), or pristimerin (30) and tingenone (31) isolated from Maytenus canariensis Kunk et Sund (Celastraceae) inhibited LPS-stimulated IL-1β production on human monocytes, with mean IC₅₀ values of 40, 56 and 58 nM. In addition, several sesquiterpene pyridine alkaloids of T. wilfordii, named wilfornines A, B and C, as well as several other related compounds, showed significant inhibitory effects on the production of a range of pro-inflammatory cytokines, including TNFα, IL-1β, IL-4, IL-2 and IFN-γ in human peripheral mononuclear cells (when assessed in the concentration of 10 μg/mL) [90]. Other sesquiterpene lactones including cynaropicrin (32), reynosin (33) and santamarine (34) from roots of Saussurea lappa Radix (Compositae) inhibited TNFα production in LPS-activated RAW 264.7 cells, with IC₅₀ values of 8.2 μM for cynaropicrin, 87.4 μM for reynosin and 105 μM for santamarine [91]. Furthermore, treatment with sulphydryl (thiol, -SH) compounds such as L-cysteine, dithiothreitol, and 2-mercaptoethanol abrogated the inhibitory effect of cynaropicrin on TNFα production. The authors have proposed that the main inhibitory component of Saussurea lappa Radix is cynaropicrin and that its action seems to be mediated through conjugation with SH-groups of target proteins [91].

Jung et al. [92] reported that reynosin (IC₅₀ = 1 μM) exhibited a concentration-dependent inhibition of CINC-1 formation in NRK-52E rat kidney epithelial cells stimulated with LPS. Moreover, the diterpenes casearinols A and B and casearinones A and B isolated from Casearia guianensis J. R. Johnston (Flacourtiaceae) were found to be effective in reducing the expression of ICAM-1 and VCAM-1 in THP-1 human monocytes [93]. Terpinen-4-ol, the main constituent of the essential oil of Melaleuca alternifolia (Maiden and Betche) Cheel (Myrtaceae) (tea tree oil) suppressed the formation of TNFα, IL-1β, IL-8, IL-10 according to an assessment in LPS-activated human peripheral blood monocytes [94].

The iridoid glycosides, such as aucubin (35), catalpol (36), swetiamarin and gardenoside represent a group of cyclopentano[c]pyran monoterpenoids and have been found as constituents of several oriental medicine plants. Aucubin prevented TNFα and IL-6 production in RBL-2H3 stimulated mast cells (IC₅₀ values of 101 and 190 ng/mL, respectively), through a mechanism involving the blockade of NF-κB activation [95]. Catalposide, the major iridoid glycoside obtained from the stem bark of Catalpa ovata G. Don (Bignoniaceae) was effective in preventing the production of TNFα, IL-1β and IL-6 in LPS-activated macrophages, possibly via NF-κB inhibition (approximate IC₅₀ value of 50 ng/mL) [96].

Interestingly, the oral administration of cannabinoids has been proposed for the treatment of multiple sclerosis, since cannabinoids seem to stimulate lymphocytes in the CNS by increasing the levels of TNFα [97]. These results are still not conclusive, but open new possibilities for the employment of cannabinoids to treat multiple sclerosis.

Other Compounds

Physalin B, a seco-steroid isolated from Physalis angulata L. (Solanaceae) produced a marked inhibition of the generation of TNFα, IL-6 and IL-12 in macrophages stimulated with LPS and IFNγ (IC₅₀ < 2 μg/mL). Physalin B (0.5 mg/mouse) also reduced the levels of TNFα in the serum of LPS-treated mice. Nevertheless, physalin B was effective in preventing the septic shock induced by LPS in mice [98].

Shikonin (37) was reported to be a component of the traditional Chinese herbal medicine, Lithospermum erythrorhizon Sieb. and Zucc. (Boraginaceae), which possesses anti-inflammatory activities [99]. Shikonin blocked the binding of RANTES (regulated upon activation on normal T-cell expressed and secreted) and MIP-1α, but not SDF-1α to human monocytes (IC₅₀ values of 3.6 and 2.6 μM, respectively) [100]. Shikonin also blocked RANTES and MIP-1α binding to human embryonic kidney (HEK)/293 cells transfected with the stable CC chemokine receptor-1 (CCR1) (IC₅₀ values of 2.63 and 2.57 μM). Furthermore, shikonin inhibited RANTES-induced CCR1 cell migration, without interfering with CCR1 cell migration induced by epidermal growth factor (EGF). The authors suggest that shikonin appears to be a highly specific antagonist for the CCR1 receptor and holds promise for the future design of more potent, highly selective therapeutics for the treatment of inflammatory autoimmune diseases [100].

Another study has indicated that the specially processed extract of radix Stephaniae tetrandrae S. Moore (Menispermaceae) (containing 1.3 % of tetrandrine and 0.7 % of fangchinoline) and the main alkaloids tetrandrine (38) and fangchinoline (39) prevented integrin-mediated neutrophil adhesion and transmigration induced by fMLP or leukotriene B₄ (IC₅₀ values between 1 to 5 μg/mL) [101]. Tetrandrine and fangchinoline also showed a marked inhibitory effect on IL-6 activity in vitro (IC₅₀ > 6 μM) [102]. These two compounds also reduced the increase of IL-β and TNFα levels in human peripheral blood mononuclear cells stimulated with Staphylococcus aureus Cowan-1 [103]. Colchicine (40) from Colchicum autumnale L. (Colchicaceae) presented a significant inhibitory effect on the induction of VCAM-1 in both TNFα- and IL-1β-stimulated HUVECs [104]. Colchicine was also found to be effective in reducing the levels of IL-6, TNFα and IL-8 in the serum of patients with familial Mediterranean fever after 2 months of treatment [105]. Likewise, colchicine down-regulated the expression of ICAM-1 and selectin on the surface of HUVECs [106].

The alkaloid piperlactam S (41) isolated from Piper kadsura (Choisy) Ohwi (Piperaceae) inhibited C5a-induced release of TNFα and IL-1β in RAW 264.7 macrophages [107]. Finally, very recently Yesilada et al. [108] reported that 55 extracts or fractions obtained from 10 plant species used in Turkish folk medicine for the treatment of rheumatism and related inflammatory diseases, showed inhibitory effects on the production of IL-1α/IL-1β and TNFα by human peripheral mononuclear cells stimulated with LPS [108].

Conclusion

Recent data from the literature demonstrate that plenty plant-derived compounds present important anti-inflammatory activities and most of their actions are related to their ability to inhibit cytokine, chemokine or adhesion molecule synthesis and/or action. As discussed before, many inflammatory disorders including sepsis, rheumatoid arthritis and asthma are intimately associated with an imbalance of the cytokine network, as well as to an exaggerated cell influx to the sites of inflammation. In fact, the pharmaceutical industries are currently making tremendous efforts in order to identify new, relevant therapeutic molecules capable of modulating cytokine- and chemokine-activated responses. These agents would be useful not only for the treatment of inflammatory disorders, but also for the control of some other diseases which present an inflammatory origin, such as atherosclerosis and Alzheimer’s disease. Although some cytokine modulators, for instance, selective blockers of IL-1β and TNFα receptors, have been employed clinically, the use of these drugs presents some disadvantages, especially regarding their high cost, important side effects and route of administration (effective therapy requires at least 2 subcutaneous injections a week). In this context, the development of therapeutic agents based on plant-derived compounds that present anti-cytokine activities would have clear benefits. Thus, plant-derived agents could be used alone or in association with other available anti-inflammatory drugs, allowing a reduction in costs and/or side effects and possibly leading to an increase in effectiveness. However, most of the anti-inflammatory studies on plant-derived compounds have been carried out in vitro, and in vivo experiments would be required to confirm their efficacy. Furthermore, only a few plant-derived compounds have been submitted to clinical trials to test their potential as anti-inflammatory agents. Finally, as most of the anti-inflammatory compounds are found in several vegetable plant species, it is tempting to suggest that many other plants, not used in folk medicine to treat inflammatory diseases, could present anti-inflammatory properties. Thus, as cytokines are critically involved in most relevant and untreatable inflammatory diseases, large scale studies with plant-derived compounds would constitute a very attractive and relevant field to identify new, effective anti-inflammatory drugs.

References

• 1 Sacca R, Cuff C A, Ruddle N H. Mediators of inflammation.  Current Opinion in Immunology. 1997;  9 851-7
• 2 Barnes P J. Cytokine modulators as novel therapies for asthma.  Annual Review in Pharmacology and Toxicology. 2002;  42 81-98
• 3 Haddad J J. Cytokines and related receptor-mediated signaling pathways.  Biochemical and Biophysical Communications. 2002;  297 700-13
• 4 Hopkins S J. The pathophysiological role of cytokines.  Legal Medicine. 2003;  5 S45-57
• 5 Dinarello C A. Pro-inflammatory cytokines.  Chest. 2000;  118 503-8
• 6 Opal S M, DePalo V A. Anti-inflammatory cytokines.  Chest. 2000;  117 1162-72
• 7 Kracht M, Saklatvala J. Transcriptional and post-transcriptional control of gene expression in inflammation.  Cytokine. 2002;  20 91-106
• 8 Barnes P J, Karin M. Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases.  The New England Journal of Medicine. 1997;  336 1006-71
• 9 Donaldson L F, Hanley M R, Villabalnca A C. Inducible receptors.  Trends in Pharamcological Sciences. 1997;  18 171-81
• 10 Luster A D. Chemokines - chemotatic cytokines that mediate inflammation.  New England Journal of Medicine. 1998;  338 436-45
• 11 Wong M M, Fish E N. Chemokines: attractive mediators of the immune response.  Seminars in Immunology. 2003;  15 5-14
• 12 D’Ambrosio D, Panina-Bordignon P, Sinigaglia F. Chemokine receptors in inflammation: an overview.  Journal of Immunological Methods. 2003;  273 3-13
• 13 Feldmann M, Brennan F M, Maini R. Cytokines in autoimmune disorders.  Internal Review in Immunology. 1998;  17 217-28
• 14 Proudfoot A EI, Power C A, Rommel C, Wells T NC. Strategies for chemokine antagonists as therapeutics.  Seminars in Immunology. 2003;  15 57-65
• 15 Young P R. Pharmacological modulation of cytokine action and production through signaling pathways.  Cytokine & Growth Factor Reviews. 1998;  9 239-57
• 16 Andreakos E T, Foxwell B M, Brennan F M, Maini R N, Feldmann M. Cytokinies and anti-cytokine biologicals in autoimmunity: present and future.  Cytokine & Growth Factor Reviews. 2002;  13 299-313
• 17 Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis.  Nature Review Immunology. 2002;  2 364-71
• 18 Habtemariam S. Natural inhibitors of tumor necrosis factor-α production, secretion and function.  Planta Medica. 2000;  66 303-13
• 19 Gerritsen M E, Carley W W, Ranges G E, Shen C P, Phan S A, Ligon G F, Perry C A. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression.  American Journal of Pathology. 1995;  147 278-92
• 20 Middleton E J r. Effect of plant flavonoids on immune and inflammatory cell function.  Advance Experimental Medicine and Biology. 1998;  439 175-82
• 21 Di Carlo G, Mascolo N, Izzo A A, Capasso F. Flavonoids: old and new aspects of a class of natural therapeutic drugs.  Life Sciences. 1999;  65 337-53
• 22 Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages.  The Journal of Pharmacology and Experimental Therapeutics. 2001;  296 181-7
• 23 Ueda H, Yamazaki C, Yamazaki M. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens .  Biological & Pharmaceutical Bulletin. 2002;  25 1197-202
• 24 Kotanidou A, Xagorari A, Bagli E, Kitsanta P, Fotsis T, Papapetropoulos A, Roussos C. Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice.  American Journal of Respiratory Critical Care in Medicine. 2002;  1165 818-23
• 25 Das M, Ram A, Ghosh B. Luteolin alleviates bronchoconstriction and airway hyperreactivity in ovalbumin sensitized mice.  Inflammation Research. 2003;  52 101-6
• 26 Manna S K, Mukhopadhyay A, Van N T, Aggrawal B B. Silymarin suppresses TNF-induced activation of NF-κB, c-Jun N-terminal kinase, and apoptosis.  The Journal of Immunology. 1999;  163 6800-9
• 27 Johnson V J, Osuchowski M F, He Q, Sharma R P. Physiological responses to a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: II. Alterations in thymic differentiation correlate with changes in c-myc gene expression.  Planta Medica. 2002;  68 961-5
• 28 Ishiwa J, Sato T, Mimaki Y, Sashida Y, Yano M, Ito A. A citrus flavonoid, nobiletin, suppresses production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts.  Journal of Rheumatology. 2000;  27 20-5
• 29 Lin N, Sato T, Takayama Y, Mimaki Y, Sashida Y, Yano M, Ito A. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages.  Biochemical Pharmacology. 2003;  65 2065-71
• 30 Kubo M, Matsuda H, Tanaka M, Kimura Y, Okuda H, Higashino M, Tani T, Namba K, Arichi S. Studies on Scutellariae radix: VII. Anti-arthritic and anti-inflammatory actions of methanolic extract and flavonoids components from Scutellariae radix.  Chemistry Pharmacology Bulletin. 1984;  32 2724-9
• 31 Chen Y -C, Shen S -C, Chen L -G, Lee T J -F, Yang L -L. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide.  Biochemical Pharmacology. 2001;  61 1417-27
• 32 Chiu J H, Lay I S, Su M Y, Chiu H L, Chiu S N, Lui W Y, Wu C W. Tumor necrosis factor-producing activity of wogonin in RAW 264.7 murine macrophage cell line.  Planta Medica. 2002;  68 1036-9
• 33 Li B Q, Fu T, Gong W -H, Dunlop N, Kung H -F, Yan Y, Kang J, Wang J M. The flavonoids baicalin exhibits anti-inflammatory activity by binding to chemokines.  Immunopharmacology. 2000;  49 295-306
• 34 Nakajima T, Imanishi M, Yamamoto K, Cyong J C, Hirai K. Inhibitory effect of baicalein, a flavonoid in Scutellaria Root, on eotaxin production by human dermal fibroblasts.  Planta Medica. 2001;  67 32-5
• 35 Kimura Y, Matsushita N, Yokoi-Hayashi K, Okuda H. Effects of baicalein isolated from Scutellaria baicalensis on adhesion molecule expression induced by thrombin and thrombin receptor agonist peptide in cultured human umbilical vein endothelial cells.  Planta Medica. 2001;  67 331-4
• 36 Sartor L, Pezzato E, Dell’Aica I, Caniato R, Biggin S, Garbisa S. Inhibition of matrix-proteases by polyphenols: chemical insights for anti-inflammatory and anti-invasion drug design.  Biochemical Pharmacology. 2002;  64 229-37
• 37 Krakauer T, Li B Q, Young H A. The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines.  FEBS Letters. 2001;  500 52-5
• 38 Shen Y C, Chiou W F, Chou Y C, Chen C F. Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes.  European Journal of Pharmacology. 2003;  465 171-81
• 39 Nakamura N, Hayasaka S, Zhang X Y, Nagaki Y, Matsumoto M, Hayasaka Y, Terasawa K. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappa B binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line.  Experimental Eye Research. 2003;  77 195-202
• 40 Wadsworth T L, McDonald T L, Koop D R. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-α.  Biochemical Pharmacology. 2001;  62 963-74
• 41 Manjeet K R, Ghosh B. Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-α production in murine macrophages.  International Journal of Immunopharmacology. 1999;  21 435-43
• 42 Wei B L, Lu C M, Tsao L T, Wang J P, Lin C N. In vitro anti-inflammatory effects of quercetin 3-O-methyl ether and other constituents from Rhamnus species.  Planta Medica. 2001;  67 745-47
• 43 Cho J Y, Kim P S, Park J, Yoo E S, Baik K U, Kim Y K, Park M H. Inhibitor of tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW264.7 cells from Amorpha fruticosa .  Journal of Ethnopharmacology. 2000;  70 127-33
• 44 Park K Y, Lee S H, Min B K, Lee K S, Choi J S, Chung S R, Min K R, Kim Y. Inhibitory effect of luteolin 4′-O-glucoside from Kummerowia striata and other flavonoids on interleukin-5 bioactivity.  Planta Medica. 1999;  65 457-9
• 45 Okabe S, Suganuma M, Imayoshi Y, Taniguchi S, Yoshida T, Fujiki H. New TNFα releasing inhibitors, geraniin and corilagin, in leaves of Acer nikoense, Megusurino-Ki.  Biological & Pharmaceutical Bulletin. 2001;  10 1145-8
• 46 Jang M K, Sohn D H, Ryu J H. A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-alpha release from Curcuma zedoaria .  Planta Medica. 2001;  67 550-2
• 47 Kang B Y, Chung S W, Kim T S. Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by hypericin, an active component of Hypericum perforatum .  Planta Medica. 2001;  67 364-6
• 48 Bork P M, Bacher S, Schimitz M L, Kaspers U, Heinrich M. Hypericin as a non-antioxidant inhibitor of NF-kappa B.  Planta Medica. 1999;  65 297-300
• 49 Oh G S, Pae H O, Choi B M, Jeong S, Oh H, Oh C S, Rho Y D, Kim D H, Shin M K, Chung H T. Inhibitory effects of the root cortex of Paeonia suffruticosa on interleukin-8 and macrophage chemoattractant protein-1 secretions in U937 cells.  Journal of Ethnopharmacology. 2003;  84 85-9
• 50 Chou T C. Anti-inflammatory and analgesic effects of paeonol in carrageenan-evoked thermal hyperalgesia.  British Journal of Pharmacology. 2003;  139 1146-52
• 51 Cho K J, Yun C H, Packer L, Chung A S. Inhibition mechanisms of bioflavonoids extracted from the bark of Pinus maritima on the expression of proinflammatory cytokines.  Annals of the New York Academy of Science. 2001;  928 141-56
• 52 Bito T, Roy S, Sen C K, Shirakawa T, Gotoh A, Ueda M, Ichihashi M, Packer L. Flavonoids differentially regulate IFN-γ-induced ICAM-1 expression in human keratinocytes: molecular mechanisms of action.  FEBS Letters. 2002;  520 145-52
• 53 Manthey J A, Grohmann K, Montanari A, Ash K, Manthey C L. Polymethoxylated flavones derived from Citrus suppress tumor necrosis factor-α expression by human monocytes.  Journal Natural Products. 1999;  62 441-4
• 54 Hunter M S, Corley D G, Carron C P, Rowold E, Kilpatrick B F, Durley R C. Four new clerodane diterpenes from the leaves of Casearia guianensis which inhibit the interaction of leukocyte function antigen 1 with intercellular adhesion molecule 1.  Journal Natural Products. 1997;  60 894-99
• 55 Ahn K S, Kim J H, Oh S R, Ryu S Y, Lee H K. Inhibitory activity of stilbenes from medicinal plants on the expression of cell adhesion molecules on THP1 cells.  Planta Medica. 2000;  66 641-4
• 56 Tanaka S, Sakata Y, Morimoto K, Tambe Y, Watanabe Y, Honda G, Tabata M, Oshima T, Masuda T, Umezawa T, Shimada M, Nagakura N, Kamisako W, Kashiwada Y, Ikeshiro Y. Influence of natural and synthetic compounds on cell surface expression of cell adhesion molecules, ICAM-1 and VCAM-1.  Planta Medica. 2001;  67 108-13
• 57 Yamazaki R, Hatano H, Aiyama R, Matsuzaki T, Hashimoto S, Yokokura T. Diarylheptanoids suppress expression of leukocyte adhesion molecules on human vascular endothelial cells.  European Journal of Pharmacology. 2000;  404 375-85
• 58 Ashikawa K, Majumdar S, Banerjee S, Bharti A C, Shishodia S, Aggarwal B B. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaB-alpha kinase and p65 phosphorylation.  The Journal of Immunology. 2002;  169 6490-7
• 59 Krakauer T. The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines.  Immunopharmacology and Immunotoxicology. 2002;  24 113-9
• 60 Jung J H, Ha J Y, Min K R, Shibata F, Nakagawa H, Kang S S, Chang I M, Kim Y. Reynosin from Sassurea lappa as inhibitor on CINC-1 induction in LPS-stimulated NRK-52E cells.  Planta Medica. 1998;  64 54-5
• 61 Tsuda T, Horio F, Osawa T. Cyanidin 3-O-beta-D-glucoside suppresses nitric oxide production during a zymosan treatment in rats.  Journal of Nutrition Sciences Vitaminol (Tokyo). 2002;  48 305-10
• 62 Ishii R, Horie M, Saito K, Arisawa M, Kitanaka S. Inhibition of lipopolysaccharide-induced pro-inflammatory cytokine expression via suppression of nuclear factor-kappaB activation by Mallotus japonicus phloroglucinol derivatives.  Biochimica et Biophysica Acta. 2003;  1620 108-18
• 63 Calixto J B, Otuki M F, Santos A RS. Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor κ B (NF-κB).  Planta Medica. 2003;  69 973-83
• 64 Natarajan C, Bright J J. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus Kinase-STAT pathway in T lymphocytes.  The Journal of Immunology. 2002;  169 6506-13
• 65 Liacini A, Sylvester J, Qing Li W, Huang W, Dehnade F, Ahmad M, Zafarullah M. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes.  Experimental Cell Research. 2003;  288 208-17
• 66 Banerjee M, Tripathi L M, Srivastava V M, Puri A, Shukla R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat.  Immunopharmacology and Immunotoxicology. 2003;  25 213-24
• 67 Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa).  The Journal of Alternative & Complementary Medicine. 2003;  9 161-8
• 68 Cheng A L, Hsu C H, Lin J K, Hsu M M, Ho Y F, Shen T S, Ko J Y, Lin J T, Lin B R, Ming-Shiang W, Yu H S, Jee S H, Chen G S, Chen T M, Chen C A, Lai M K, Pu Y S, Pan M H, Wang Y J, Tsai C C, Hsieh C Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.  Anticancer Research. 2001;  21 2895-900
• 69 Aggarwal B B, Kumar A, Bharti A C. Anticancer potential of curcumin: preclinical and clinical studies.  Anticancer Research. 2003;  23 363-98
• 70 Oh S R, Kim D S, Lee I S, Jung K Y, Lee J J, Lee H K. Anticomplementary activity of constituents from the heartwood of Caesalpinia sappan .  Planta Medica. 1998;  64 456-8
• 71 Oh G T, Choi J H, Hong J J, Kim D Y, Lee S B, Kim J R, Lee C H, Hyun B H, Oh S R, Bok S H, Jeong T S. Dietary hematein ameliorates fatty streak lesions in the rabbit by the possible mechanism of reducing VCAM-1 and MCP-1 expression.  Atherosclerosis. 2001;  159 17-26
• 72 Hong J J, Jeong T S, Choi J H, Park J H, Lee K Y, Seo Y J, Oh S R, Oh G T. Hematein inhibits tumor necrotic factor-alpha-induced vascular cell adhesion molecule-1 and NF-kappaB-dependent gene expression in human vascular endothelial cells.  Biochemical and Biophysical Research Communications. 2001;  281 1127-33
• 73 Choi J H, Jeong T S, Kim D Y, Kim Y M, Na H J, Nam K H, Lee S B, Kim H C, Oh S R, Choi Y K, Bok S H, Oh G T. Hematein inhibits atherosclerosis by inhibition of reactive oxygen generation and NF-kappaB-dependent inflammatory mediators in hyperlipidemic mice.  Journal of Cardiovascular Pharmacology. 2003;  42 287-95
• 74 Cho J Y, Park J, Yoo E S, Yoshikawa K, Baik K U, Lee J, Park M H. Inhibitory effect of lignans from the rhizomes of Coptis japonica var. dissecta on tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW264.7 cells.  Archive of Pharmacal Research. 1998;  21 12-6
• 75 Cho J Y, Baik K U, Yoo E S, Yoshikawa K, Park M H. In vitro anti-inflammatory effects of neolignan woorenosides from the rhizomes of Coptis japonica .  Journal of Natural Products. 2000;  63 1205-9
• 76 Cho J Y, Park J, Kim P S, Yoo E S, Baik K U, Park M H. Savinin, a lignan from Pterocarpus santalinus inhibits tumor necrosis factor-alpha production and T cell proliferation.  Biological & Pharmaceutical Bulletin. 2001;  24 167-71
• 77 Cho J Y, Kim A R, Park M H. Lignans from the rhizomes of Coptis japonica differentially act as anti-inflammatory principles.  Planta Medica. 2001;  67 312-6
• 78 Su B -N, Takaishi Y, Kusumi T. Morinols A-L, twelve novel sesquineolignans and neolignans with a new carbon skeleton from Morina chinensis .  Tetrahedron. 1999;  55 14 571-86
• 79 Chavali S R, Forse R A. Decreased production of interleukin-6 and prostaglandin E₂ associated with inhibition of delta-5 desaturation of omega6 fatty acids in mice fed safflower oil diets supplemented with sesamol.  Prostaglandins, Leukotrienes and Essential Fatty Acids. 1999;  61 347-52
• 80 Utsunomiya T, Chavali S R, Zhong W W, Forse R A. Effects of sesamin-supplemented dietary fat emulsions on the ex vivo production of lipopolysaccharide-induced prostanoids and tumor necrosis factor α in rats.  The American Journal of Clinical Nutrition. 2000;  72 804-8
• 81 Ahn K S, Jung K Y, Kim J H, Oh S R, Lee H K. Inhibitory activity of lignan components from the flower buds of Magnoliae fargesii on the expression of cell adhesion molecules.  Biological & Pharmaceutical Bulletin. 2001;  24 1085-7
• 82 Sylvester J, Liacini A, Li W Q, Dehnade F, Zafarullah M. Tripterygium wilfordii Hook F extract suppresses proinflammatory cytokine-induced expression of matrix metalloproteinase genes in articular chondrocytes by inhibiting activating protein-1 and nuclear factor-κB activities.  Molecular Pharmacology. 2001;  59 1196-205
• 83 Allison A C, Cacabelos R, Lombardi V RM, Álvarez X A, Vigo C. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer’s disease.  Progress Neuro-Psychopharmacology & Biological Psychiatry. 2001;  25 1341-57
• 84 Koch E, Klaas C A, Rungeler P, Castro V, Mora G, Vichnewski W, Merfort I. Inhibition of inflammatory cytokine production and lymphocyte proliferation by structurally different sesquiterpene lactones correlates with their effect on activation of NF-kappaB.  Biochemical Pharmacology. 2001;  62 795-801
• 85 Schnyder B, Schnyder-Candrian S, Panski A, Bömmel H, Heim M, Duschl A, Moser R. Phytochemical inhibition of interleukin-4-activated Stat6 and expression of VCAM-1.  Biochemical and Biophysical Research Communications. 2002;  292 841-7
• 86 Humar M, Garcia-Pineres A J, Castro V, Merfort I. Effect of sesquiterpene lactones on the expression of the activation marker CD69 and of IL-2 in T-lymphocytes in whole blood.  Biochemical Pharmacology. 2003;  65 1551-63
• 87 Cho J Y, Yoo E S, Baik K U, Park M H, Han B H. In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-alpha production and its modulation by known TNF-alpha antagonists.  Planta Medica. 2001;  67 13-8
• 88 Kim Y K, Kim R G, Park S J, Ha J H, Choi J W, Park H J, Lee K T. In vitro anti-inflammatory activity of kalopanaxsaponin A isolated from Kalopanax pictus in murine macrophage RAW 264.7 cells.  Biological & Pharmaceutical Bulletin. 2002;  25 72-6
• 89 Huang F C, Chan W K, Moriarty K J, Zhang D C, Chang M, He W, Yu K T, Zilberstein A. Novel cytokine release inhibitors. Part I: triterpenes.  Bioorganic & Medical Chemistry Letters. 1998;  8 1883-6
• 90 Duan H, Takaishi Y, Momota H, Ohmoto Y, Taki T, Jia Y, Li D. Immunosuppressive sesquiterpene alkaloids from Tripterygium wilfordii .  Journal of Natural Products. 2001;  64 582-7
• 91 Cho J Y, Park J, Yoo E S, Baik K U, Jung J H, Lee J, Park M H. Inhibitory effect of sesquiterpene lactones from Saussurea lappa on tumor necrosis factor-alpha production in murine macrophage-like cells.  Planta Medica. 1998;  64 594-7
• 92 Jung J H, Ha J Y, Min K R, Shibata F, Nakagawa H, Kang S S, Chang I M, Kim Y. Reynosin from Sassurea lappa as inhibitor on CINC-1 induction in LPS-stimulated NRK-52E cells.  Planta Medica. 1998;  64 454-5
• 93 Hunter M S, Corley D G, Carron C P, Rowold E, Kilpatrick B F, Durley R C. Four new clerodane diterpenes from the leaves of Casearia guianensis which inhibit the interaction of leukocyte function antigen 1 with intercellular adhesion molecule 1.  Journal of Natural Products. 1997;  60 894-9
• 94 Hart P H, Brand C, Carson C F, Riley T V, Prager R H, Finlay-Jones J J. Terpinen-4-ol, the main component of the essential oil of Malaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes.  Inflammation Research. 2000;  49 619-26
• 95 Jeong H J, Koo H N, Na H J, Kim M S, Hong S H, Eom J W, Kim K S, Shin T Y, Kim H M. Inhibition of TNF-alpha and IL-6 production by Aucubin through blockade of NF-kappaB activation RBL-2H3 mast cells.  Cytokine. 2002;  18 252-9
• 96 An S J, Pae H O, Oh G S, Choi B M, Jeong S, Jang S I, Oh H, Kwon T O, Song C E, Chung H T. Inhibition of TNF-alpha, IL-1beta, and IL-6 productions and NF-kappa B activation in lipopolysaccharide-activated RAW 264.7 macrophages by catalposide, an iridoid glycoside isolated from Catalpa ovata G. Don (Bignoniaceae).  International Immunopharmacology. 2002;  2 1173-81
• 97 Killestein J, Hoogervorst E L, Reif M, Blauw B, Smits M, Uitdehaag B M, Nagelkerken L, Polman C H. Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis.  Journal of Neuroimmunology. 2003;  137 140-3
• 98 Soares M B, Bellintani M C, Ribeiro I M, Tomassini T C, Ribeiro dos Santos R. Inhibition of macrophage activation and lipopolysaccaride-induced death by seco-steroids purified from Physalis angulata L.  European Journal of Pharmacology. 2003;  459 107-12
• 99 Tanaka S, Tajima M, Tsukada M, Tabata M. A comparative study on anti-inflammatory activities of the enantiomers, shikonin and alkannin.  Journal of Natural Products. 1986;  49 66-9
• 100 Chen X, Oppenheim J, Howard O MZ. Shikonin, a component of anti-inflammatory Chinese herbal medicine, selectively blocks chemokines binding to CC chemokines receptor-1.  International Immunopharmacology. 2001;  1 229-36
• 101 Shen Y -C, Chou C -J, Chiou W -F, Chen C -F. Anti-inflammatory effects of the partially purified extract of radix Stephanie tetrandrae: comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions.  Molecular Pharmacology. 2001;  60 1983-90
• 102 Choi H S, Kim H S, Min K R, Kim Y, Lim H K, Chang Y K, Chung M W. Anti-inflammatory effects of fangchinoline and tetrandrine.  Journal of Ethnopharmacology. 2000;  69 173-9
• 103 Onai N, Tsunokawa Y, Suda M, Watanabe N, Nakamura K, Sugimoto Y, Kobayashi Y. Inhibitory effects of bisbenzylisoquinoline alkaloids on induction of proinflammatory cytokines, interleukin-1 and tumor necrosis factor-alpha.  Planta Medica. 1995;  61 497-501
• 104 Asahina A, Tada Y, Nakamura K, Tamaki K. Colchicine and griseofulvin inhibit VCAM-1 expression on human vascular endothelial cells - evidence for the association of VCAM-1 expression with microtubules.  Journal of Dermatological Science. 2001;  25 1-9
• 105 Kiraz S, Ertenli I, Arici M, Calguneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S. Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.  Clinical and Experimental Rheumatology. 1998;  16 721-4
• 106 Perico N, Ostermann D, Bontempeill M, Morigi M, Amuchastegui C S, Zoja C, Akalin E, Sayegh M H, Remuzzi G. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.  Journal of the American Society of Nephrology. 1996;  7 594-601
• 107 Chiou W F, Peng C H, Chen C F, Chou C J. Anti-inflammatory properties of piperlactam S: modulation of complement 5a-induced chemotaxis and inflammatory cytokines production in macrophages.  Planta Medica. 2003;  69 9-14
• 108 Yesilada E, Üstün O, Sezik E, Takaishi Y, Ono Y, Honda G. Inhibitory effects of Turkish folk remedies on inflammatory cytokines: interleukin-1α, interleukin-1β and tumor necrosis factor α.  Journal of Ethnopharmacology. 1997;  58 59-73